From NPC therapeutic target identification to potential treatment strategy

Molecular Cancer Therapeutics

Volumn 9, Issue 9, 2010, Pages 2511-2523

  Lan, Ming Ying ^a,b,g   Chen, Chi Long ^c,d   Lin, Kuan Ting ^b,e   Lee, Sheng An ^h   Yang, Wu Lung R ^f   Hsu, Chun Nan ^e,i   Wu, Jaw Ching ^b   Ho, Ching Yin ^b,g   Lin, Jin Ching ^a,b   Huang, Chi Ying F ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h KAINAN UNIVERSITY   (Taiwan)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CYTOTOXICITY; GENE EXPRESSION; HUMAN; NASOPHARYNX CARCINOMA; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR TARGETED THERAPY; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77956596734     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0966     Document Type: Article

References (50)

1. Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007;9:1-24.
2. Lee YC, Hwang YC, Chen KC, et al. Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma. Funct Integr Genomics 2007;7:79-93.
3. Chen X, Liang S, Zheng W, Liao Z, Shang T, Ma W. Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation. BMC Genomics 2008;9:322.
4. Sriuranpong V, Mutirangura A, Gillespie JW, et al. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 2004;10:4944-58.
5. Shi W, Bastianutto C, Li A, et al. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 2006;119:2467-75.
6. Zeng ZY, Zhou YH, Zhang WL, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 38:120-33.
7. Fang W, Li X, Jiang Q, et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008;6:32.
8. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-77.
9. Chou J, Lin YC, Kim J, et al. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 2008;30:946-63.
10. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001;411:41-2.
11. Batada NN, Hurst LD, Tyers M. Evolutionary and physiological importance of hub proteins. PLoS Comput Biol 2006;2:e88.
12. Lee SA, Chan CH, Chen TC, et al. POINeT: protein interactome with sub-network analysis and hub prioritization. BMC Bioinformatics 2009;10:114.
13. Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007;7:54-60.
14. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006;313:1929-35.
15. Wei G, Twomey D, Lamb J, et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 2006;10:331-42.
16. De Preter K, De Brouwer S, Van Maerken T, et al. Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds. Clin Cancer Res 2009;15:3690-6.
17. Ebi H, Tomida S, Takeuchi T, et al. Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res 2009;69:4027-35.
18. Hsu CN, Chang YM, Kuo CJ, Lin YS, Huang HS, Chung IF. Integrating high dimensional bi-directional parsing models for gene mention tagging. Bioinformatics 2008;24:i286-94.
19. Lin KT, Liu CH, Chiou JJ, Tseng WH, Lin KL, Hsu CN. Gene name service: no-nonsense alias resolution service for homo sapiens genes. Proceedings of the 2007 IEEE/WIC/ACM International Conference on Web Intelligence and Intelligent Agent Technology Workshops (WI-IAT Workshops 2007); 2007 Nov 5; Silicon Valley. Washington (DC): IEEE; 2007.
20. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human protein reference database-2009 update. Nucleic Acids Res 2009;37:D767-72.
21. Luc PV, Tempst P. PINdb: a database of nuclear protein complexes from human and yeast. Bioinformatics 2004;20:1413-5.
22. Ruepp A, Brauner B, Dunger-Kaltenbach I, et al. CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res 2008;36:D646-50.
23. Kamburov A, Wierling C, Lehrach H, Herwig R. ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res 2009;37:D623-8.
24. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
25. Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 2008;36:D684-8.
26. Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008;36:D901-6.
27. Lin CT, Chan WY, Chen W, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993;68:716-27.
28. Liao SK, Perng YP, Shen YC, Chung PJ, Chang YS, Wang CH. Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion. Cancer Genet Cytogenet 1998;103:52-8.
29. Chen TC, Lee SA, Chan CH, et al. Cliques in mitotic spindle network bring kinetochore-associated complexes to form dependence pathway. Proteomics 2009;9:4048-62.
30. Spirin V, Mirny LA. Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci U S A 2003;100:12123-8.
31. Frouin I, Montecucco A, Biamonti G, Hubscher U, Spadari S, Maga G. Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. EMBO J 2002;21:2485-95.
32. Ellison V, Stillman B. Reconstitution of recombinant human replication factor C (RFC) and identification of an RFC subcomplex possessing DNA-dependent ATPase activity. J Biol Chem 1998;273:5979-87.
33. Lee SH, Kwong AD, Pan ZQ, Hurwitz J. Studies on the activator 1 protein complex, an accessory factor for proliferating cell nuclear antigen-dependent DNA polymerase δ. J Biol Chem 1991;266:594-602.
34. Uhlmann F, Cai J, Flores-Rozas H, et al. In vitro reconstitution of human replication factor C from its five subunits. Proc Natl Acad Sci U S A 1996;93:6521-6.
35. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000;14:927-39.
36. Hayano T, Yanagida M, Yamauchi Y, Shinkawa T, Isobe T, Takahashi N. Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome. J Biol Chem 2003;278:34309-19.
37. Bouwmeester T, Bauch A, Ruffner H, et al. A physical and functional map of the human TNF-α/NF-κ B signal transduction pathway. Nat Cell Biol 2004;6:97-105.
38. Leong JL, Loh KS, Putti TC, Goh BC, Tan LK. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 2004;114:153-7.
39. Pan J, Kong L, Lin S, Chen G, Chen Q, Lu JJ. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma. Laryngoscope 2008;118:1970-5.
40. Ma BB, Poon TC, To KF, et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma-a prospective study. Head Neck 2003;25:864-72.
41. Bar-Sela G, Kuten A, Ben-Eliezer S, Gov-Ari E, Ben-Izhak O. Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach. Mod Pathol 2003;16:1035-40.
42. Yan J, Fang Y, Huang BJ, Liang QW, Wu QL, Zeng YX. Absence of evidence for HER2 amplification in nasopharyngeal carcinoma. Cancer Genet Cytogenet 2002;132:116-9.
43. Bose S, Yap LF, Fung M, et al. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J Pathol 2009;217:345-52.
44. Weinberg RA. P53 and apoptosis: master guardian and executioner. In: Weinberg RA, editor. The Biology of Cancer. New York: Garland Science; 2007, p. 307-56.
45. Li L, Guo L, Tao Y, et al. Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases. Cancer Lett 2007;255:219-31.
46. Ogino T, Moriai S, Ishida Y, et al. Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma. Int J Cancer 2007;120:2401-10.
47. Ho SY, Guo HR, Chen HH, Hsiao JR, Jin YT, Tsai ST. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma. Head Neck 2004;26:977-83.
48. Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g: Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 2007;35:W193-200.
49. Gil-Ad I, Shtaif B, Levkovitz Y, et al. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 2006;15:107-12.
50. Zhelev Z, Ohba H, Bakalova R, et al. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Cancer Chemother Pharmacol 2004;53:267-75.